Glutamate receptors (GluRs) are ubiquitously present in the central nervous system (CNS) as the major mediators of excitatory neurotransmission and excitotoxicity. Neural injury associated with trauma, stroke, epilepsy, and many neurodegenerative diseases such as Alzheimer's, Huntington's, and Parkinson's diseases and amyotrophic lateral sclerosis may be mediated by excessive activation of GluRs. Neurotoxicity associated with excitatory amino acids encountered in food, such as domoic acid and monosodium glutamate, has also been linked to GluRs. Less is known about GluRs outside the CNS. Recent observations suggest that several subtypes of GluRs are widely distributed in peripheral tissues. Using immunochemical and molecular techniques, the presence of GluR subtypes was demonstrated in the rat and monkey heart, with preferential distribution within the conducting system, nerve terminals, and cardiac ganglia. GluR subtypes NMDAR 1,GluR 2/3, and mGluR 2/3 are also present in kidney, liver, lung, spleen, and testis. Further investigations are needed to assess the role of these receptors in peripheral tissues and their importance in the toxicity of excitatory compounds. Therefore, food safety assessment and neurobiotechnology focusing on drugs designed to interact with GluRs should consider these tissues as potential target/effector sites.
INTRODUCTION
Glutamate receptors (GluRs) have been studied extensively in the mammalian central nervous system (CNS), where they mediate most of the excitatory neurotransmission (5, 8, 13, 25) . They play a pivotal role in synaptic plasticity and in the formation of neural networks during development (8, 13) . However, glutamate and related excitatory amino acids are toxic to the CNS neurons (7, 15, 17, 19, 24-26, 34, 35) . Excessive activation of the GluRs during stress to the brain, which occurs during ischemia, head trauma, and epileptic seizures, results in death of neurons. Glutamate neurotoxicity may also be involved in the genesis and progression of various neurodegenerative disease (7, 18, 19) . The GluRs are thought to play a pivotal role in the physiology and pathology of brain functions.
Although the presence of GluRs is well documented in the CNS, their role in peripheral tissues is just beginning to emerge. Functional ionotropic glutamate receptors (iGluRs) are induced with terminal differentiation of the embryonal carcinogenic cell lines NT2 and P 19 into neuronlike cells by retinoic acid treatment (12) . In addition, glutamate agonists induce various cellular responses in peripheral tissues, such as a rise in intracellular cal-cium concentration in the rat pituitary cell and the stimulation of growth hormone. They also induce the release of insulin and glucagon from the rat endocrine pancreas and the contraction of the myenteric plexus-longitudinal muscle of the guinea pig ileum (14, 32, 35, (37) (38) (39) . Current evidence indicates that the GluRs are present in the following tissues: lungs (29, 30) , sensory ganglia (37) , adrenal and pineal glands (20, 37) , tongue (3), pancreas (11, 14, 38) , pituitary (36) , vestibular system (6) , bone (4) , gut (1, 31) , and heart (9, 10, 21, 22, 28) . In the rat and monkey heart, these receptors are preferentially localized to the intrinsic cardiac ganglia, nerve fibers, and specific components of the conducting systems (9, 10, 23) .
The aim of this study was to further investigate the potential target/effector sites for excitatory compounds, which could be important in the toxicologic assessment of foods and therapeutic products. Using immunochemical and molecular methods (9, 10, 22, 27) , we investigated the presence of the GluR subtypes NMDAR 1 (Nmethyl-D-aspartate), GluR 2/3, and mGluR 2/3 in a variety of peripheral tissues, ie, the kidney, liver, lung, spleen, and testis.
MATERIALS AND METHODS
Tissue Preparation and Immunohistochemistry. Adult male Sprague-Dawley rats (Charles River Canada, Montreal, PQ, Canada) were housed individually in Health FIGURE Kidneys of rats perfused with 4% paraformaldehyde and processed for histopathology/immunochemistry. Microwaved paraffinembedded sections were immunostained for anti-mGluR 2/3, anti-GluR 2/3, and anti-NMDAR 1 using avidin-biotin with diaminobenzidine as chromogen. A) Renal cortex. H&E. B) Anti-NMDAR 1 with strong positive staining in distal convoluted tubule (DT), mesangium (M), glomerulus (G), proximal tubule (PT), and podocytes (T). C) Strong anti-mGluR 2/3 reaction in the juxtaglomerular apparatus (JGA) and proximal tubules. D) Very strong anti-mGluR 2/3 in granular cells in wall of afferent arteriole (AA). E) Anti-GluR 2/3 reaction similar to anti-mGluR 2/3. F) Negative stain of antibodies incubated with corresponding peptide 1 hour before application.
Guard Cages (Research Equipment Co, Bryan, TX, USA) under conditions meeting the requirements of the Canadian Council for Animal Care. All rats were acclimatized for 1 week. Rats were anaesthetized with isoflurane and perfused, and tissues of interest were collected and immersed and fixed in 4% buffered paraformaldehyde. The tissues were then embedded in paraffin, and sections (4) (5) [tm) were mounted on silanated slides. The sections were dewaxed and microwaved for antigen recovery (23, 27) . Slides were then processed for immunohistochemistry using the avidin-biotin method with streptavidin horseradish peroxidase conjugate (LAB/Dakopatts, Di Armed Forces Institute of Pathology, Washington, DC, USA). Photographs were taken with a microscope (Axiophot, Zeiss, Geneva, Germany) equipped with a digital camera and linked to an image analysis system (Progres 3012 camera, ROCHE Image Analysis and Archiving System, Zeiss Canada, Toronto, Canada).
Controls. Brain sections were used as positive controls for each antibody tested. For negative controls, the diluent solution (LAB/Dakopatts) containing 15% normal serum was substituted for the antibody. Preabsorption controls were prepared for all the tissues tested and for the brain using peptides for mGluR 2/3, GluR 2/3, and NMDAR 1. These solutions were custom synthesized (Quality Controlled Biochemical Inc, Hopkinton, MA, USA) using the peptide sequences provided by Chemicon International. Each peptide ranging from 1.0 f.1g/f.11 to 0.004 f.1g/f.11 was incubated with the optimal concentration of the specific antibody at room temperature for 1 hour prior to placing the mixture on the slides. PCR Analysis. The sequences of primers used for reverse transcription polymerase chain reaction (RT-PCR) have been previously described (12, 14, 38) . Total RNA was extracted from rat brain (Trizol Reagent, Gibco/BRL, Burlington, ON, Canada) according to the manufacturer's protocol. For RT-PCR analysis, different concentrations of mRNA for kidney, liver, lung, spleen, and testis (ClonTech, San Francisco, CA, USA) were used for first strand cDNA synthesis using the Superscript II reverse transcriptase (Gibco/BRL) with the oligo(dT) primer. The cDNAs were then amplified by PCR using gene-specific primers and Taq enzyme (Promega, Madison, WI, USA).
The PCR conditions were denaturation at 94°C for 1 minute, annealing for 45-55°C for 1 minute, and extension at 68°C for 1 minute. Thirty-five cycles were used for amplification followed by an extension at 68°C for 10 minutes. Aliquots of the products were separated on a 2% agarose gel. Southern Hybridizations. Amplified cDNA fragments generated for NMDAR 1 and GluR 3 from the total RNA of the rat were extracted from the agarose gel using Qiaquick columns. An aliquot of cDNA was fractionated by electrophoresis through a 1 % (w/v) agarose gel and transferred to a nylon membrane (Schleicher and Schuell, Keene, NH, USA) using the a transfer system (Turboblotter Rapid Downward Transfer System, Schleicher and Schuell). For the probe, the fragment corresponding to the NMDAR 1 receptor was labeled (DIG-High Prime, Roche Diagnostics, Laval, Quebec, Canada). The unlabeled nucleotides were removed and the labeled fragment was used in hybridizations. Prehybridization and hybridization were performed at 55°C using the hybridization solution as recommended by the supplier (DIG Easy, Roche Diagnostics). The filters were washed twice for 15 minutes at room temperature in 1 X saline sodium citrate (SSC), 0.25% sodium dodecyl sulfate (SDS) and once for 20 minutes at 60°C in 0.l X SSC, 0.25% SDS. Immunochemical detection (Detection starter kit 11, Roche Diagnostics) proceeded as follows. The filter was washed for 10 minutes in washing buffer and then blocking for 30 minutes. Anti-DIG-AP conjugate was added (1: 10,000) directly to the blocking solution and incubated for 30 minutes. The filter was washed twice in washing buffer for 15 minutes. The detection was done using chemiluminscent substrate. Blots were exposed to X-ray film for 10 seconds.
RESULTS

Kidney
All 3 receptors were present in the kidney with an overall preferential distribution within cortical structures. Anti-NMDAR 1 (0.006 f.1g/f.1I) immunoreactivity was present ( Figure 1B ) in glomeruli and convoluted proximal and distal tubules. Glomeruli showed strong preferential labeling of the mesangium and podocytes. Anti-mGluR 2/3 (0.003 f.1g/f.11) immunostaining was stronger in convoluted proximal tubule than in glomeruli. A unique finding was the presence of strongly immunoreactive mGluR 2/3 in the juxtaglomerular apparatus. At this location, a coarse granular, intense perinuclear cytoplasmic staining was observed in the granular cells at the wall of the afferent arteriole. The stain in this location was such that it could be used to identify this structure at low magnification (Figure 1 C, D). Anti-GluR 2/3 (0.007 tJLg/~l) immunostain distribution was similar to that of mGluR 2/3 (0.007)JLg/)JLl). It also showed immunolabeling of the afferent arteriole, but the stain was less intense ( Figure IE ). The specificity of labeling was confirmed by the blocking of the reaction when antibodies were incubated with their corresponding peptide 1 hour prior to placing the mixture on the slides ( Figure IF) . Controls where the antibody was omitted were also negative.
Testis
A cross-section of the adult rat testis demonstrating the differential distribution of mGluR 2/3, GluR 2/3, and NMDAR 1 is depicted in Figure 2 . Anti-NMDARl (0.006 f.1g/f.1I) had the widest distribution of all the antibodies tested, with strong immunostaining seen in the epithelium of the seminiferous tubules and in the cells of the interstitial space. Spermatogonia and spermatocytes adjacent to the basal lamina and the more mature spermatids near the lumen of the germinal epithelium showed the strongest stain. Immunolabeling was also localized within the interstitial or Leydig cells and to a lesser extent within the myoid cells. At all locations, the stain had a granular appearance with a perinuclear cytoplasmatic cellular distribution (Figure 2C, D) . In contrast, anti-GluR 2/3 (0.003 f.1g/f.1l) immunostain was limited to the interstitial spaces, where it appeared in the wall of the arterioles and in the interstitial or Leydig cells (Figure 2E , F). As with the other antibodies, anti-mGluR 2/3 (0.003 f.1g/f.11) showed specific affinity for myoid and interstitial cells, which acquired an intense perinuclear cytoplasmic stain. Immunoreactivity with anti-mGluR 2/3 was also seen in the germinal epithelium but was mainly limited to the mature spermatids and spermatozoa and particularly localized to the sperm head. The intensity of the stain varied within a cross-section of seminiferous tubules according to the different stages of maturation of the germinal epithelium (Figure 2G -I). No stain was observed when each of the antibodies was incubated with its corresponding peptide for 1 hour prior to placing the mixture on the slides ( Figure 2B ). Lung All antibodies tested show positive reaction in the adult rat lung. However, each had a specific differential distribution and intensity, as illustrated in Figure 3 . Immunoreaction with anti-NMDAR 1 (0.002 f.1g/f.11) showed the widest distribution of the receptor antibodies tested, as was observed with the other tissues. The immunostain was localized to the alveolar walls, bronchiolar epithelium, and endothelial lining ( Figure 3B ). Anti-GluR 2/3 (0.01 f.1g/f.11) showed a preferential affinity for the endothelial lining and bronchiolar epithelium ( Figure 3C , D). Anti-mGluR 2/3 (0.01 f.1g/f.1I) immunostain had a distribution similar to that of GluR 2/3 but with higher affinity for the bronchiolar and alveolar epithelial lining ( Figure  3E ). Mast cells could be readily observed at lower magnification because of their strong stain. After absorption controls, the stain was absent in all structures except the mast cells, for which the intensity was reduced ( Figure   3F ).
Liver and Spleen
Immunostaining was also observed in liver and spleen; however, total peptide adsorption was not achieved. ~ ~T herefore, to confirm the presence of the GluRs in these tissues, PCR analysis was done for the subtypes NMDAR 1 and GluR 3. The brain was used as a positive control. In all tissues examined, the expected PCR products of 500 and 460 base pairs were observed for NMDAR 1 and GluR 3, respectively. Further verification was done by Southern hybridizations, in which PCR products obtained from brain RNA were isolated from agarose gel, labeled, and used as a probe. Signals corresponding to products of expected size were obtained from all the tissues tested ( Figure 4B ).
DISCUSSION
We demonstrated the presence and cellular distribution of the GluR subunits NMDAR 1, GluR 2/3, and mGluR 2/3 in the kidney, liver, lung, spleen, and testis of rats.
These receptors were selected as prototypes for the NMDA, AMPA, and mGluR subunits within the large family of GluRs. Each GluR tested had a specific cellular distribution within each tissue analyzed. The subtype NMDAR 1 was the most widely distributed. Similar observations were reported in heart (9, 10, 22) and bone (4) . Previously, we reported the presence of GluRs in the intramural ganglia, the nerve fibers, and the conducting system of the heart in rat and monkey (9, 10, 22) . The data presented here support the view that GluRs subtypes have a wide and specific distribution (4, 6, 9-11, 14, 20-22, 29, 30, 32, 36, 38, 39) in tissues outside the CNS.
In the CNS, there is overwhelming evidence indicating that GluRs play an important role in the induction of neural cell injury and in the pathology of a variety of acute and chronic degenerative diseases and disorders such as epilepsy, ischemic, hypoglycemia, hypoxia, and head trauma (7, 13, 19) . The view that excessive activation of the NMDAR 1 causes neuronal death in the CNS is shared by many investigators (7, 22, 43) . Because this receptor subtype is also the most prevalent in peripheral tissues (5, 9, 10, 22, this study), it is possible that it also mediates cellular injury at these sites.
The localization of the GluRs to specific anatomical structures in peripheral tissues alludes to their importance in the control of cellular hemostatic mechanisms, cell differentiation, excitability, cell injury, and metabolism (5, 28-30, 38, 39) . Their presence in several endocrine organs such as pancreas, pituitary, testis, and kidney implicates these receptors in the regulation of hormone secretion (14) . This hypothesis is supported by the work of Inagaki et al (14) , who showed that the iGluRs are involved in the regulation of Cay signaling and participate in the regulation of insulin secretion in the pancreatic 13 cells. In addition, these receptors can also act as media--FIGURE 2.-Testis of adult rats perfused with 4% paraformaldehyde and processed for histopathology/immunochemistry. Microwaved paraffinembedded sections were immunostained for anti-mGluR 2/3, anti-GluR 2/3, and anti-NMDAR I using avidin-biotin with diaminobenzidine as chromogen. A) Cross-section of seminiferous tubule (ST) and interstital space (IS). H&E. B) Negative stain with antibodies incubated with corresponding peptide 1 hour before application. C) Anti-NMDAR 1 positive stain in germinal epithelium and IS. D) Anti-NMDAR 1 strong affinity for spermatogonium (SG) and spermatocytes adjacent to basal lamina; more mature spermatids (SP) near lumen. E) Anti-GluR 2/3 affinity only for interstitial tissue. F) Anti-GluR 2/3 immunostain of interstitial cells and wall of arteriole. G) Anti-mGluR 2/3 with affinity for interstitial tissue and germinal epithelium. H, 1) Marked staining for anti-mGluR 2/3 in heads of mature SP and interstitial and myoid cells (I). FIGURE 3.-Lungs of rats perfused with 4% paraformaldehyde and processed for histopathology/immunochemistry. Microwaved paraffin-embedded sections were immunostained for anti-mGluR 2/3, anti-GluR 2/3, and anti-NMDAR 1 using avidin-biotin with diaminobenzidine as chromogen.
A) Relevant structures in the lung. H&E. B) Anti-NMDAR 1 diffuse affinity for alveolar walls, bronchiolar epithelium, and endothelial lining. C, D) Anti-GluR 2/3 with preferential affinity for endothelial lining, bronchiolar epithelium, and mast cells (MS). E) Anti-mGluR 2/3 with similar distribution as GluR 2/3 but stronger affinity for bronchiolar and alveolar epithelial lining. F) No staining was observed except with MS after incubation of antibodies with corresponding peptide for 1 hour. A = alveoli; AD = alveolar duct; END = endothelium; TB = terminal bronchiole. tors of injury and inflammation through a common injury pathway (10, 19, 29, 30) . In the CNS, this form of injury appears to be predominantly mediated by excessive influx of Ca +2 into neurons through the ion channels, triggered by the stimulation of GluRs (18, 19) . Because GluRs are ion-gated channels selective to Na+, K+, and Cay, any overactivation of these channels could result in depolar-ization. This depolarization would activate the voltagegated Ca +2 channels and would contribute to a series of membrane, cytoplasmic, and nuclear events that would result in toxicity (18, 19) . The major excitatory amino acid, glutamate, could be synthesized or stimulated by variety of inflammatory mediators, including arachidonate metabolites and reactive oxygen free radicals. As a FIGURE 4.-PCR amplification of the NMDAR 1 GluR. For the brain, total RNA was used for RT-PCR; for the rest of the tissues, mRNA was used. A) Lane 1 = brain; lane 2 = kidney; lane 3 = testis; lane 4 = 1-kb ladder, molecular marker (Invitrogen), size 1 kb-100 base pairs (bp), increment of 100 bp. The molecular weight for the fragment for the NMDAR 1 was approximately 500 bp. B) Southern hybridization using the PCR-purified fragment generated in the brain as a probe. The purified cDNA fragment with corresponding NMDAR 1 was labeled and used in hybridization. Signals are observed in 2 tissues tested. Lane 1 = brain; lane 2 = kidney; lane 3 = testis. result, an increase in Ca+2 could lead to injury in peripheral tissues (29, 30) . This suggestion is supported by the findings that the enzyme phosphatase-activated glutaminase is present in the glucagon-secreting a cells in the pancreas (14, 38) , pancreatic ganglia (14, 38) , bone (4), and bone marrow (4) .
Although the function of GluRs in peripheral tissues has yet to be determined with certainty, various functions may be assigned to them based on their cellular distribution. In the kidney, the wide distribution of NMDAR 1 and the presence of mGluR 2/3 and GluR 2/3 in the juxta glomerular apparatus (JGA) and proximal tubules suggest that these receptors may be involved in electrolytes and water homeostasis. The strong visualization of immunoreactive mGluR 2/3 and GluR 2/3 within the granular cells of the afferent arteriole suggests a potential involvement in the control of renin release. The reninangiotensin system is a major hormonal system involved in the regulation of electrolytes, fluid balance, and blood pressure (16) . In addition to the GluR subunits, the dopamine receptors (Dla, D2, and D3) have been reported in different regions, including the JGA of the kidney (23, 31, 40) . These receptors are implicated in renal hemodynamics, ion transport, and renin secretion. It has yet to be determined whether there is colocalization or cofunctionality of the GluRs and dopamine receptors. The differential distribution of GluRs in the testosterone-producing Leydig cells and in the germinal epithelium of the seminiferous tubules of the testis suggest that each receptor subtype or combination may have a specific role in spermatogenesis and hormone regulation. To test this hypothesis, we are currently investigating the presence of GluRs in testis during various developmental stages. In the lungs, other investigators (29, 30) have shown that excessive activation of the NMDAR 1 may provoke acute edema and lung injury as seen in adult respiratory distress syndrome. This injury can further be modulated by blockage of 1 of 3 critical steps: NMDAR 1 binding, inhibition of NO synthesis, or activation of poly(ADPribose) polymerase (29, 30) .
The presence of similar neurotransmitter receptors in peripheral tissues is not new. Receptors such as dopamine and gamma-aminobutyric acid have also been reported in the peripheral tissues (2, 24, 31, 40, 42) . In these locations, these receptors have electrophysiologic and pharmacologic properties similar to those found in neuronal cells.
Peripheral tissues containing GluRs are potential target effector sites for neurotransmission and excitotoxicity. These observations are important in food toxicology, particularly because there are a variety of excitatory compounds that include glutamate that can be found in food products, either as natural by-products (protein hydrolates) or food contaminants (domoic acid) or as additives in food processing (monosodium glutamate and aspartame). The excitatory actions of these compounds are believed to be mediated through the GluRs (17, 19, 25) . Whether or not these excitatory sites are active in peripheral tissues and how they compare to those described for the CNS has yet to be determined. From the toxicologic point of view, GluRs in organs such as kidney and heart may provide an explanation for the renal and peripheral vascular effects that have been associated with potent excitotoxins such as domoic acid (33, 35) and for the cardiovascular and autonomic response seen in some susceptible individuals in association with the ingestion of monosodium glutamate (3, 41) . Furthermore, there is also growing interest within the pharmaceutical industry in developing therapeutic products specifically designed to interact with synaptic transmission GluRs in the brain (5, 17, 43) . These potential peripheral target sites should be considered during evaluation of these therapeutic products. Further research is required to assess the significance and role of the GluRs in the peripheral tissues and their impact in the toxicology of excitatory amino acids and other compounds.
